tradingkey.logo

Tempus AI Inc

TEM
54.910USD
+2.470+4.71%
종가 02/06, 16:00ET시세는 15분 지연됩니다
9.76B시가총액
손실P/E TTM

Tempus AI Inc

54.910
+2.470+4.71%

자세한 내용은 Tempus AI Inc 회사

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Tempus AI Inc 정보

종목 코드 TEM
회사 이름Tempus AI Inc
상장일May 30, 2025
CEOLefkofsky (Eric P)
직원 수2400
유형Ordinary Share
회계 연도 종료May 30
주소600 West Chicago Avenue
도시CHICAGO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호60654
전화18335144187
웹사이트https://investors.tempus.com/
종목 코드 TEM
상장일May 30, 2025
CEOLefkofsky (Eric P)

Tempus AI Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
752.09K
-135234.00%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
102.70K
-1322.00%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
14.71K
-1997.00%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
10.43K
-2447.00%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-17168.00%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
3.61K
-250.00%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
1.25K
-1997.00%
Mr. Eric P. Lefkofsky, J.D.
Mr. Eric P. Lefkofsky, J.D.
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Erik J. Phelps, J.D.
Mr. Erik J. Phelps, J.D.
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
--
--
Dr. Jennifer A. Doudna, Ph.D.
Dr. Jennifer A. Doudna, Ph.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
752.09K
-135234.00%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
102.70K
-1322.00%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
14.71K
-1997.00%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
10.43K
-2447.00%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-17168.00%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
3.61K
-250.00%

수익 분석

기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Wed, Feb 4
마지막 업데이트: Wed, Feb 4
주주
주주 유형
주주
주주
비율
Blue Media, LLC
10.49%
BK TL21 LLC
8.80%
Lefkofsky (Eric Paul)
6.77%
The Vanguard Group, Inc.
5.92%
Gray Media, LLC
5.36%
기타
62.65%
주주
주주
비율
Blue Media, LLC
10.49%
BK TL21 LLC
8.80%
Lefkofsky (Eric Paul)
6.77%
The Vanguard Group, Inc.
5.92%
Gray Media, LLC
5.36%
기타
62.65%
주주 유형
주주
비율
Investment Advisor
31.87%
Corporation
29.32%
Investment Advisor/Hedge Fund
11.69%
Individual Investor
7.45%
Research Firm
5.18%
Hedge Fund
4.27%
Holding Company
3.13%
Bank and Trust
0.95%
Venture Capital
0.91%
기타
5.24%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
742
96.30M
55.71%
+4.89M
2025Q3
619
75.72M
43.81%
-4.20M
2025Q2
501
136.83M
81.41%
-3.18M
2025Q1
444
136.54M
81.24%
-3.30M
2024Q4
259
141.87M
89.45%
+26.80M
2024Q3
171
136.39M
89.94%
+26.38M
2024Q2
115
132.44M
88.72%
+132.44M

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Blue Media, LLC
18.14M
10.49%
-7.69M
-29.78%
Aug 08, 2025
BK TL21 LLC
15.22M
8.8%
--
--
Mar 18, 2025
Lefkofsky (Eric Paul)
11.70M
6.77%
-16.83K
-0.14%
Nov 25, 2025
The Vanguard Group, Inc.
9.42M
5.45%
+1.70M
+22.05%
Sep 30, 2025
Gray Media, LLC
9.27M
5.36%
-133.25K
-1.42%
Aug 08, 2025
Baillie Gifford & Co.
9.69M
5.61%
-2.40M
-19.86%
Sep 30, 2025
Red Sky LLC
8.06M
4.66%
-1.44M
-15.13%
Sep 30, 2025
ARK Investment Management LLC
7.18M
4.15%
-246.00K
-3.31%
Sep 30, 2025
SoftBank Group Corp
5.41M
3.13%
--
--
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
ARK Genomic Revolution ETF
12.02%
ARK Innovation ETF
5.1%
Global X HealthTech ETF
4.22%
Franklin Genomic Advancements ETF
3.92%
Renaissance IPO ETF
3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
3.05%
AXS Green Alpha ETF
2.92%
ROBO Global Artificial Intelligence ETF
2.49%
First Trust Health Care Alphadex Fund
2.42%
Innovator IBD 50 Fund ETF
2.22%
더 보기
ARK Genomic Revolution ETF
비율12.02%
ARK Innovation ETF
비율5.1%
Global X HealthTech ETF
비율4.22%
Franklin Genomic Advancements ETF
비율3.92%
Renaissance IPO ETF
비율3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
비율3.05%
AXS Green Alpha ETF
비율2.92%
ROBO Global Artificial Intelligence ETF
비율2.49%
First Trust Health Care Alphadex Fund
비율2.42%
Innovator IBD 50 Fund ETF
비율2.22%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI